How Much Upside is Left in Exagen (XGN)? Wall Street Analysts Think 73.05%

Wall Street analysts’ average price target implies 73.1% upside for Exagen (XGN), a notably bullish signal for the stock. The article also points to a favorable trend in earnings estimate revisions, which could support further upside despite the limitations of price targets as a predictive metric.

Analysis

Wall Street analysts’ average price target implies 73.1% upside for Exagen (XGN), a notably bullish signal for the stock. The article also points to a favorable trend in earnings estimate revisions, which could support further upside despite the limitations of price targets as a predictive metric.